Literature DB >> 16735092

Effect of beta-dystroglycan processing on utrophin/Dp116 anchorage in normal and mdx mouse Schwann cell membrane.

K Hnia1, G Hugon2, A Masmoudi3, J Mercier2, F Rivier2, D Mornet4.   

Abstract

In the peripheral nervous system, utrophin and the short dystrophin isoform (Dp116) are co-localized at the outermost layer of the myelin sheath of nerve fibers; together with the dystroglycan complex. Dp116 is associated with multiple glycoproteins, i.e. sarcoglycans, and alpha- and beta-dystroglycan, which anchor the cytoplasmic protein subcomplex to the extracellular basal lamina. In peripheral nerve, matrix metalloproteinase activity disrupts the dystroglycan complex by cleaving the extracellular domain of beta-dystroglycan. Metalloproteinase creates a 30 kDa fragment of beta-dystroglycan, leading to a disruption of the link between the extracellular matrix and the cell membrane. Here we asked if the processing of the beta-dystroglycan could influence the anchorage of Dp116 and/or utrophin in normal and mdx Schwann cell membrane. We showed that metalloproteinase-9 was more activated in mdx nerve than in wild-type ones. This activation leads to an accumulation of the 30 kDa beta-dystroglycan isoform and has an impact on the anchorage of Dp116 and utrophin isoforms in mdx Schwann cells membrane. Our results showed that Dp116 had greater affinity to the full length form of beta-dystroglycan than the 30 kDa form. Moreover, we showed for the first time that the short isoform of utrophin (Up71) was over-expressed in mdx Schwann cells compared with wild-type. In addition, this utrophin isoform (Up71) seems to have greater affinity to the 30 kDa beta-dystroglycan which could explain the increased stabilization of this 30 kDa form at the membrane compartment. Our results highlight the potential participation of the short utrophin isoform and the cleaved form of beta-dystroglycan in mdx Schwann cell membrane architecture. We proposed that these two proteins could be implicated in Schwann cell proliferation in response to a microenvironment stress such as mediated by accumulating macrophages in mdx mouse muscle inflammation sites.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16735092      PMCID: PMC1974842          DOI: 10.1016/j.neuroscience.2006.04.043

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  51 in total

1.  Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix.

Authors:  O Ibraghimov-Beskrovnaya; J M Ervasti; C J Leveille; C A Slaughter; S W Sernett; K P Campbell
Journal:  Nature       Date:  1992-02-20       Impact factor: 49.962

2.  An alternative dystrophin transcript specific to peripheral nerve.

Authors:  T J Byers; H G Lidov; L M Kunkel
Journal:  Nat Genet       Date:  1993-05       Impact factor: 38.330

3.  Laminin-binding protein 120 from brain is closely related to the dystrophin-associated glycoprotein, dystroglycan, and binds with high affinity to the major heparin binding domain of laminin.

Authors:  S H Gee; R W Blacher; P J Douville; P R Provost; P D Yurchenco; S Carbonetto
Journal:  J Biol Chem       Date:  1993-07-15       Impact factor: 5.157

4.  Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates.

Authors:  C Heussen; E B Dowdle
Journal:  Anal Biochem       Date:  1980-02       Impact factor: 3.365

5.  Monoclonal antibodies targeted against the C-terminal domain of dystrophin or utrophin.

Authors:  E Fabbrizio; J Léger; M Anoal; J J Léger; D Mornet
Journal:  FEBS Lett       Date:  1993-05-03       Impact factor: 4.124

Review 6.  Dystrophin and dystrophin-related proteins: a review of protein and RNA studies.

Authors:  D R Love; B C Byth; J M Tinsley; D J Blake; K E Davies
Journal:  Neuromuscul Disord       Date:  1993-01       Impact factor: 4.296

7.  Formation of multiple complexes between beta-dystroglycan and dystrophin family products.

Authors:  M Royuela; D Chazalette; G Hugon; R Paniagua; V Guerlavais; J A Fehrentz; J Martinez; J P Labbe; F Rivier; D Mornet
Journal:  J Muscle Res Cell Motil       Date:  2003       Impact factor: 2.698

8.  Localization of the DMDL gene-encoded dystrophin-related protein using a panel of nineteen monoclonal antibodies: presence at neuromuscular junctions, in the sarcolemma of dystrophic skeletal muscle, in vascular and other smooth muscles, and in proliferating brain cell lines.

Authors:  T M Nguyen; J M Ellis; D R Love; K E Davies; K C Gatter; G Dickson; G E Morris
Journal:  J Cell Biol       Date:  1991-12       Impact factor: 10.539

9.  Primary structure of dystrophin-related protein.

Authors:  J M Tinsley; D J Blake; A Roche; U Fairbrother; J Riss; B C Byth; A E Knight; J Kendrick-Jones; G K Suthers; D R Love
Journal:  Nature       Date:  1992-12-10       Impact factor: 49.962

10.  Characterisation of matrix metalloproteinases and the effects of a broad-spectrum inhibitor (BB-1101) in peripheral nerve regeneration.

Authors:  M Demestre; G M Wells; K M Miller; K J Smith; R A C Hughes; A J Gearing; N A Gregson
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

View more
  8 in total

Review 1.  Finding the sweet spot: assembly and glycosylation of the dystrophin-associated glycoprotein complex.

Authors:  Dewayne Townsend
Journal:  Anat Rec (Hoboken)       Date:  2014-09       Impact factor: 2.064

2.  Drp2 and periaxin form Cajal bands with dystroglycan but have distinct roles in Schwann cell growth.

Authors:  Diane L Sherman; Lai Man N Wu; Matthew Grove; C Stewart Gillespie; Peter J Brophy
Journal:  J Neurosci       Date:  2012-07-04       Impact factor: 6.167

3.  L-arginine decreases inflammation and modulates the nuclear factor-kappaB/matrix metalloproteinase cascade in mdx muscle fibers.

Authors:  Karim Hnia; Jérôme Gayraud; Gérald Hugon; Michèle Ramonatxo; Sabine De La Porte; Stefan Matecki; Dominique Mornet
Journal:  Am J Pathol       Date:  2008-05-05       Impact factor: 4.307

Review 4.  Biological role of dystroglycan in Schwann cell function and its implications in peripheral nervous system diseases.

Authors:  Toshihiro Masaki; Kiichiro Matsumura
Journal:  J Biomed Biotechnol       Date:  2010-06-15

5.  Novel Nuclear Protein Complexes of Dystrophin 71 Isoforms in Rat Cultured Hippocampal GABAergic and Glutamatergic Neurons.

Authors:  Rafael Rodríguez-Muñoz; María Del Carmen Cárdenas-Aguayo; Víctor Alemán; Beatriz Osorio; Oscar Chávez-González; Alvaro Rendon; Dalila Martínez-Rojas; Marco Antonio Meraz-Ríos
Journal:  PLoS One       Date:  2015-09-17       Impact factor: 3.240

6.  Evidence of the involvement of dystrophin Dp71 in corneal angiogenesis.

Authors:  Gabriella Ortiz; Ophélie Vacca; Romain Bénard; Bénédicte Dupas; Florian Sennlaub; Xavier Guillonneau; Sahel Ja; Ramin Tadayoni; Alvaro Rendon; Audrey Giocanti-Aurégan
Journal:  Mol Vis       Date:  2019-11-14       Impact factor: 2.367

7.  Perlecan is recruited by dystroglycan to nodes of Ranvier and binds the clustering molecule gliomedin.

Authors:  Cristina Colombelli; Marilena Palmisano; Yael Eshed-Eisenbach; Desirée Zambroni; Ernesto Pavoni; Cinzia Ferri; Stefania Saccucci; Sophie Nicole; Raija Soininen; Karen K McKee; Peter D Yurchenco; Elior Peles; Lawrence Wrabetz; M Laura Feltri
Journal:  J Cell Biol       Date:  2015-02-02       Impact factor: 10.539

Review 8.  Dystrophin Dp116: A yet to Be Investigated Product of the Duchenne Muscular Dystrophy Gene.

Authors:  Masafumi Matsuo; Hiroyuki Awano; Masaaki Matsumoto; Masashi Nagai; Tatsuya Kawaguchi; Zhujun Zhang; Hisahide Nishio
Journal:  Genes (Basel)       Date:  2017-10-02       Impact factor: 4.096

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.